mupirocin and its Impurities

Mupirocin is used as a topical treatment for bacterial skin infections. It is used as a cream or ointment applied to the skin. It is sold under the brand name Bactroban. Reference standards of Mupirocin API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.

Displaying 34 results for mupirocin Impurities
Drug Reference Standards & Impurity Synthesis in India
PA 13 61000

Mupirocin

Mupirocin


  • Catalogue No.:PA 13 61000

  • CAS :

    12650-69-0

  • Molecular Formula : C26H44O9

  • Molecular Weight : 500.62

Drug Reference Standards & Impurity Synthesis in India
PA 13 61010

Mupirocin - Impurity A

Pseudomonic Acid B


  • Catalogue No.:PA 13 61010

  • CAS :

    40980-51-6

  • Molecular Formula : C26H44O10

  • Molecular Weight : 516.62

Drug Reference Standards & Impurity Synthesis in India
PA 13 61020

Mupirocin - Impurity B

Pseudomonic Acid C


  • Catalogue No.:PA 13 61020

  • CAS :

    71980-98-8

  • Molecular Formula : C26H44O8

  • Molecular Weight : 484.62

Drug Reference Standards & Impurity Synthesis in India
PA 13 61030

Mupirocin - Impurity C

Pseudomonic Acid D Sodium


  • Catalogue No.:PA 13 61030

  • CAS :

    85178-60-5

  • Molecular Formula : C26H41NaO9

  • Molecular Weight : 520.59

Drug Reference Standards & Impurity Synthesis in India
PA 13 61031

Mupirocin - Impurity C (Freebase)

Pseudomonic Acid D


  • Catalogue No.:PA 13 61031

  • CAS :

    85248-93-7

  • Molecular Formula : C26H42O9

  • Molecular Weight : 498.61

Drug Reference Standards & Impurity Synthesis in India
PA 13 61040

Mupirocin - Impurity D

9-[[(2E)-4-[(2R,3aS,6S,7S)-2-[(2S,3S)-1,3-Dihydroxy-2-methylbutyl]-7-hydroxyhexahydro-4H-furo[3,2-c]pyran-6-yl]-3-methylbut-2-enoyl]oxy]nonanoic Acid Sodium Salt


  • Catalogue No.:PA 13 61040

  • CAS :

    116182-43-5

  • Molecular Formula : C26H43NaO9

  • Molecular Weight : 522.60

Drug Reference Standards & Impurity Synthesis in India
PA 13 61041

Mupirocin - Impurity D (Freebase)

9-[[(2E)-4-[(2R,3aS,6S,7S)-2-[(2S,3S)-1,3-Dihydroxy-2-methylbutyl]-7-hydroxyhexahydro-4H-furo[3,2-c]pyran-6-yl]-3-methylbut-2-enoyl]oxy]nonanoic Acid


  • Catalogue No.:PA 13 61041

  • CAS :

    71087-97-3

  • Molecular Formula : C26H44O9

  • Molecular Weight : 500.62

Drug Reference Standards & Impurity Synthesis in India
PA 13 61050

Mupirocin - Impurity E

9-[[(2E)-4-[(2R,3RS,4aS,7S,8S,8aR)-3,8-Dihydroxy-2-[(1S,2S)-2-hydroxy-1-methylpropyl]hexahydro-2H,5H-pyrano[4,3-b]pyran-7-yl]-3-methylbut-2-enoyl]oxy]nonanoic Acid Sodium Salt


  • Catalogue No.:PA 13 61050

  • CAS :

    116182-44-6

  • Molecular Formula : C26H43NaO9

  • Molecular Weight : 522.60

Drug Reference Standards & Impurity Synthesis in India
PA 13 61051

Mupirocin - Impurity E (Freebase)

9-[[(2E)-4-[(2R,3RS,4aS,7S,8S,8aR)-3,8-Dihydroxy-2-[(1S,2S)-2-hydroxy-1-methylpropyl]hexahydro-2H,5H-pyrano[4,3-b]pyran-7-yl]-3-methylbut-2-enoyl]oxy]nonanoic Acid


  • Catalogue No.:PA 13 61051

  • CAS :

    71087-96-2

  • Molecular Formula : C26H44O9

  • Molecular Weight : 500.62

Drug Reference Standards & Impurity Synthesis in India
PA 13 61060

Mupirocin - Impurity F

7-[[(2E)-4-[(2S,3R,4R,5S)-3,4-Dihydroxy-5-[[(2S,3S)-3-[(1S,2S)-2-hydroxy-1-methylpropyl]oxiranyl]methyl]tetrahydro-2H-pyran-2-yl]-3-methylbut-2-enoyl]oxy]heptanoic Acid


  • Catalogue No.:PA 13 61060

  • CAS :

    167842-64-0

  • Molecular Formula : C24H40O9

  • Molecular Weight : 472.57

Drug Reference Standards & Impurity Synthesis in India
PA 13 61090

Mupirocin - Impurity I

9-[[(2E)-4-[(2S,3R,4R,5S)-3,4-Dihydroxy-5-[(3-hydroxy-4,5-dimethyltetrahydrofuran-2-yl)methyl]tetrahydro-2H-pyran-2-yl]-3-methylbut-2-enoyl]oxy]nonanoic Acid


  • Catalogue No.:PA 13 61090

  • CAS :

    NA

  • Molecular Formula : C26H44O9

  • Molecular Weight : 500.64

Drug Reference Standards & Impurity Synthesis in India
PA 13 61510

11-(((E)-4-((2S,3R,4R,5S)-3,4-Dihydroxy-5-(((2S,3S)-3-((2S,3S)-3-hydroxybutan-2-yl)oxiran-2-yl)methyl)tetrahydro-2H-pyran-2-yl)-3-methylbut-2-enoyl)oxy)undecanoic Acid

11-(((E)-4-((2S,3R,4R,5S)-3,4-Dihydroxy-5-(((2S,3S)-3-((2S,3S)-3-hydroxybutan-2-yl)oxiran-2-yl)methyl)tetrahydro-2H-pyran-2-yl)-3-methylbut-2-enoyl)oxy)undecanoic Acid


  • Catalogue No.:PA 13 61510

  • CAS :

    167842-57-1

  • Molecular Formula : C28H48O9

  • Molecular Weight : 528.68

Drug Reference Standards & Impurity Synthesis in India
PA 13 61520

(E)-Decyl 4-((2S,3R,4R,5S)-3,4-dihydroxy-5-(((2S,3S)-3-((2S,3S)-3-hydroxybutan-2-yl)oxiran-2-yl)methyl)tetrahydro-2H-pyran-2-yl)-3-methylbut-2-enoate

(E)-Decyl 4-((2S,3R,4R,5S)-3,4-dihydroxy-5-(((2S,3S)-3-((2S,3S)-3-hydroxybutan-2-yl)oxiran-2-yl)methyl)tetrahydro-2H-pyran-2-yl)-3-methylbut-2-enoate


  • Catalogue No.:PA 13 61520

  • CAS :

    153900-96-0

  • Molecular Formula : C27H48O7

  • Molecular Weight : 484.67

Drug Reference Standards & Impurity Synthesis in India
PA 13 61530

9-(((E)-4-((2S,3R,4R,5S)-5-(((2S,3S)-3-((2S,3S)-3-((9-(((E)-4-((2S,3R,4R,5S)-3,4-Dihydroxy-5-(((2S,3S)-3-((2S,3S)-3-hydroxybutan-2-yl)oxiran-2-yl)methyl)tetrahydro-2H-pyran-2-yl)-3-methylbut-2-enoyl)oxy)nonanoyl)oxy)butan-2-yl)oxiran-2-yl)methyl)-3,4-dihydroxytetrahydro-2H-pyran-2-yl)-3-methylbut-2-enoyl)oxy)nonanoic Acid

9-(((E)-4-((2S,3R,4R,5S)-5-(((2S,3S)-3-((2S,3S)-3-((9-(((E)-4-((2S,3R,4R,5S)-3,4-Dihydroxy-5-(((2S,3S)-3-((2S,3S)-3-hydroxybutan-2-yl)oxiran-2-yl)methyl)tetrahydro-2H-pyran-2-yl)-3-methylbut-2-enoyl)oxy)nonanoyl)oxy)butan-2-yl)oxiran-2-yl)methyl)-3,4-dihydroxytetrahydro-2H-pyran-2-yl)-3-methylbut-2-enoyl)oxy)nonanoic Acid


  • Catalogue No.:PA 13 61530

  • CAS :

    NA

  • Molecular Formula : C52H86O17

  • Molecular Weight : 983.23

Drug Reference Standards & Impurity Synthesis in India
PA STI 065620

Monic Acid A-d5 (d4 Major)

Monic Acid A-d5 (d4 Major)


  • Catalogue No.:PA STI 065620

  • CAS :

    NA

  • Molecular Formula : C17H23D5O7

  • Molecular Weight : 349.43

Drug Reference Standards & Impurity Synthesis in India
PA 13 61540

Monic Acid A

Monic Acid A


  • Catalogue No.:PA 13 61540

  • CAS :

    66262-68-8

  • Molecular Formula : C17H28O7

  • Molecular Weight : 344.4

Drug Reference Standards & Impurity Synthesis in India
PA 13 61550

Dihydro Mupirocin

Dihydro Mupirocin


  • Catalogue No.:PA 13 61550

  • CAS :

    1246812-11-2

  • Molecular Formula : C26H46O9

  • Molecular Weight : 502.65

Drug Reference Standards & Impurity Synthesis in India
PA EPM3805000

Mupirocin - reference spectrum (M3805000)

Mupirocin - reference spectrum (M3805000)


  • Catalogue No.:PA EPM3805000

  • CAS :

    NA

  • Molecular Formula : NA

  • Molecular Weight : NA

Drug Reference Standards & Impurity Synthesis in India
PA EPM3805500

Mupirocin calcium - reference spectrum (M3805500)

Mupirocin calcium - reference spectrum (M3805500)


  • Catalogue No.:PA EPM3805500

  • CAS :

    NA

  • Molecular Formula : NA

  • Molecular Weight : NA

Drug Reference Standards & Impurity Synthesis in India
PA EPM3806000

Mupirocin lithium (M3806000)

Mupirocin lithium (M3806000)


  • Catalogue No.:PA EPM3806000

  • CAS :

    NA

  • Molecular Formula : NA

  • Molecular Weight : NA

Drug Reference Standards & Impurity Synthesis in India
PA USP1448901

Mupirocin (1448901)

Mupirocin (1448901)


  • Catalogue No.:PA USP1448901

  • CAS :

    12650-69-0

  • Molecular Formula : NA

  • Molecular Weight : NA

Drug Reference Standards & Impurity Synthesis in India
PA USP1448912

Mupirocin Calcium (1448912)

Mupirocin Calcium (1448912)


  • Catalogue No.:PA USP1448912

  • CAS :

    115074-43-6

  • Molecular Formula : NA

  • Molecular Weight : NA

Drug Reference Standards & Impurity Synthesis in India
PA USP1448923

Mupirocin Lithium (1448923)

Mupirocin Lithium (1448923)


  • Catalogue No.:PA USP1448923

  • CAS :

    73346-79-9

  • Molecular Formula : NA

  • Molecular Weight : NA

Drug Reference Standards & Impurity Synthesis in India
PA BP804RB

mupirocin lithium (804RB)

mupirocin lithium (804RB)


  • Catalogue No.:PA BP804RB

  • CAS :

    NA

  • Molecular Formula : NA

  • Molecular Weight : NA

Drug Reference Standards & Impurity Synthesis in India
PA 13 61560

Sodium 9-(((E)-4-((2S,3aS,6S,7S,7aR)-2-((2S,3S)-1,3-dihydroxy-2-methylbutyl)-7-hydroxyhexahydro-4H-furo[3,2-c]pyran-6-yl)-3-methylbut-2-enoyl)oxy)nonanoate

Sodium 9-(((E)-4-((2S,3aS,6S,7S,7aR)-2-((2S,3S)-1,3-dihydroxy-2-methylbutyl)-7-hydroxyhexahydro-4H-furo[3,2-c]pyran-6-yl)-3-methylbut-2-enoyl)oxy)nonanoate


  • Catalogue No.:PA 13 61560

  • CAS :

    NA

  • Molecular Formula : C26H43NaO9

  • Molecular Weight : 522.61

Drug Reference Standards & Impurity Synthesis in India
PA 13 0611000

11-(((E)-4-((2S,3R,4R,5S)-5-(((2S,3S)-3-((2S,3S)-3-((9-(((E)-4-((2S,3R,4R,5S)-3,4-Dihydroxy-5-(((2S,3S)-3-((2S,3S)-3-hydroxybutan-2-yl)oxiran-2-yl)methyl)tetrahydro-2H-pyran-2-yl)-3-methylbut-2-enoyl)oxy)nonanoyl)oxy)butan-2-yl)oxiran-2-yl)methyl)-3,4-dihydroxytetrahydro-2H-pyran-2-yl)-3-methylbut-2-enoyl)oxy)undecanoic Acid

11-(((E)-4-((2S,3R,4R,5S)-5-(((2S,3S)-3-((2S,3S)-3-((9-(((E)-4-((2S,3R,4R,5S)-3,4-Dihydroxy-5-(((2S,3S)-3-((2S,3S)-3-hydroxybutan-2-yl)oxiran-2-yl)methyl)tetrahydro-2H-pyran-2-yl)-3-methylbut-2-enoyl)oxy)nonanoyl)oxy)butan-2-yl)oxiran-2-yl)methyl)-3,4-dihydroxytetrahydro-2H-pyran-2-yl)-3-methylbut-2-enoyl)oxy)undecanoic Acid


  • Catalogue No.:PA 13 0611000

  • CAS :

    NA

  • Molecular Formula : C54H90O17

  • Molecular Weight : 1011.3

Drug Reference Standards & Impurity Synthesis in India
PA 13 0611001

9-Oxodecyl (E)-4-((2S,3R,4R,5S)-3,4-dihydroxy-5-((3-hydroxy-4,5-dimethyltetrahydrofuran-2-yl)methyl)tetrahydro-2H-pyran-2-yl)-3-methylbut-2-enoate

9-Oxodecyl (E)-4-((2S,3R,4R,5S)-3,4-dihydroxy-5-((3-hydroxy-4,5-dimethyltetrahydrofuran-2-yl)methyl)tetrahydro-2H-pyran-2-yl)-3-methylbut-2-enoate


  • Catalogue No.:PA 13 0611001

  • CAS :

    NA

  • Molecular Formula : C27H46O8

  • Molecular Weight : 498.66

Drug Reference Standards & Impurity Synthesis in India
PA 13 0611002

9-(((E)-4-((2S,3R,4R,5S)-5-((4S,5S)-2-Chloro-3,5-dihydroxy-4-methylhexyl)-3,4-dihydroxytetrahydro-2H-pyran-2-yl)-1-hydroxy-3-methylbut-2-en-1-yl)oxy)nonanoic acid

9-(((E)-4-((2S,3R,4R,5S)-5-((4S,5S)-2-Chloro-3,5-dihydroxy-4-methylhexyl)-3,4-dihydroxytetrahydro-2H-pyran-2-yl)-1-hydroxy-3-methylbut-2-en-1-yl)oxy)nonanoic acid


  • Catalogue No.:PA 13 0611002

  • CAS :

    NA

  • Molecular Formula : C26H47ClO9

  • Molecular Weight : 539.1

Drug Reference Standards & Impurity Synthesis in India
PA 13 0611003

Benzyl 9-(((E)-4-((2S,3R,4R,5S)-3,4-dihydroxy-5-(((2S,3S)-3-((2S,3S)-3-hydroxybutan-2-yl)oxiran-2-yl)methyl)tetrahydro-2H-pyran-2-yl)-3-methylbut-2-enoyl)oxy)nonanoate

Benzyl 9-(((E)-4-((2S,3R,4R,5S)-3,4-dihydroxy-5-(((2S,3S)-3-((2S,3S)-3-hydroxybutan-2-yl)oxiran-2-yl)methyl)tetrahydro-2H-pyran-2-yl)-3-methylbut-2-enoyl)oxy)nonanoate


  • Catalogue No.:PA 13 0611003

  • CAS :

    NA

  • Molecular Formula : C33H50O9

  • Molecular Weight : 590.75

Drug Reference Standards & Impurity Synthesis in India
PA 13 0611004

Mupirocin Phenoxyethyl Ester

Mupirocin Phenoxyethyl Ester


  • Catalogue No.:PA 13 0611004

  • CAS :

    NA

  • Molecular Formula : C34H52O10

  • Molecular Weight : 620.78

Drug Reference Standards & Impurity Synthesis in India
PA 13 0611005

1-Glyceryl-Monostearate Ester of Mupirocin

1-Glyceryl-Monostearate Ester of Mupirocin


  • Catalogue No.:PA 13 0611005

  • CAS :

    NA

  • Molecular Formula : C47H84O12

  • Molecular Weight : 841.18

Drug Reference Standards & Impurity Synthesis in India
PA 13 0611006

9-(((E)-4-((2S,3R,4R,5S)-5-((4S,5S)-2-Chloro-3,5-dihydroxy-4-methylhexyl)-3,4-dihydroxytetrahydro-2H-pyran-2-yl)-3-methylbut-2-enoyl)oxy)nonanoic Acid

9-(((E)-4-((2S,3R,4R,5S)-5-((4S,5S)-2-Chloro-3,5-dihydroxy-4-methylhexyl)-3,4-dihydroxytetrahydro-2H-pyran-2-yl)-3-methylbut-2-enoyl)oxy)nonanoic Acid


  • Catalogue No.:PA 13 0611006

  • CAS :

    NA

  • Molecular Formula : C26H45ClO9

  • Molecular Weight : 537.09

Drug Reference Standards & Impurity Synthesis in India
PA 13 0611007

9-(((E)-4-((2S,3R,4R,5S)-5-(((2S,3S)-3-((2S,3S)-3-((9-(((E)-4-((1S,2S,3R,4R)-2,3-Dihydroxy-4-(((2S,3S)-3-((2S,3S)-3-hydroxybutan-2-yl)oxiran-2-yl)methyl)cyclohexyl)-3-methylbut-2-enoyl)oxy)nonanoyl)oxy)butan-2-yl)oxiran-2-yl)methyl)-3,4-dihydroxytetrahydro-2H-pyran-2-yl)-3-methylbut-2-enoyl)oxy)nonanoic Acid

9-(((E)-4-((2S,3R,4R,5S)-5-(((2S,3S)-3-((2S,3S)-3-((9-(((E)-4-((1S,2S,3R,4R)-2,3-Dihydroxy-4-(((2S,3S)-3-((2S,3S)-3-hydroxybutan-2-yl)oxiran-2-yl)methyl)cyclohexyl)-3-methylbut-2-enoyl)oxy)nonanoyl)oxy)butan-2-yl)oxiran-2-yl)methyl)-3,4-dihydroxytetrahydro-2H-pyran-2-yl)-3-methylbut-2-enoyl)oxy)nonanoic Acid


  • Catalogue No.:PA 13 0611007

  • CAS :

    NA

  • Molecular Formula : C53H88O16

  • Molecular Weight : 981.27

Drug Reference Standards & Impurity Synthesis in India
PA 13 0611008

(E)-9-(((E)-4-((2S,3R,4R,5S)-3,4-Dihydroxy-5-(((2S,3S)-3-((2S,3S)-3-hydroxybutan-2-yl)oxiran-2-yl)methyl)tetrahydro-2H-pyran-2-yl)-3-methylbut-2-enoyl)oxy)non-2-enoic Acid

(E)-9-(((E)-4-((2S,3R,4R,5S)-3,4-Dihydroxy-5-(((2S,3S)-3-((2S,3S)-3-hydroxybutan-2-yl)oxiran-2-yl)methyl)tetrahydro-2H-pyran-2-yl)-3-methylbut-2-enoyl)oxy)non-2-enoic Acid


  • Catalogue No.:PA 13 0611008

  • CAS :

    NA

  • Molecular Formula : C26H42O9

  • Molecular Weight : 498.61

pharmaffiliates